BRPI0715728A2 - tratamento de distérbio cartilaginosos - Google Patents

tratamento de distérbio cartilaginosos

Info

Publication number
BRPI0715728A2
BRPI0715728A2 BRPI0715728-2A2A BRPI0715728A BRPI0715728A2 BR PI0715728 A2 BRPI0715728 A2 BR PI0715728A2 BR PI0715728 A BRPI0715728 A BR PI0715728A BR PI0715728 A2 BRPI0715728 A2 BR PI0715728A2
Authority
BR
Brazil
Prior art keywords
treatment
cartilaginous disorder
cartilaginous
disorder
Prior art date
Application number
BRPI0715728-2A2A
Other languages
English (en)
Inventor
Alberto Gimona
Christoph H Ladel
Elmar Vom Baur
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Priority claimed from PCT/EP2007/058830 external-priority patent/WO2008023063A2/en
Publication of BRPI0715728A2 publication Critical patent/BRPI0715728A2/pt
Publication of BRPI0715728A8 publication Critical patent/BRPI0715728A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0715728A 2006-08-25 2007-08-24 tratamento de distúrbios cartilaginosos BRPI0715728A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06119557 2006-08-25
US84060006P 2006-08-28 2006-08-28
PCT/EP2007/058830 WO2008023063A2 (en) 2006-08-25 2007-08-24 Treatment of cartilage disorders with fgf-18

Publications (2)

Publication Number Publication Date
BRPI0715728A2 true BRPI0715728A2 (pt) 2013-09-17
BRPI0715728A8 BRPI0715728A8 (pt) 2018-04-03

Family

ID=37684849

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0715728A BRPI0715728A8 (pt) 2006-08-25 2007-08-24 tratamento de distúrbios cartilaginosos

Country Status (11)

Country Link
CN (1) CN101505787B (pt)
BR (1) BRPI0715728A8 (pt)
DK (1) DK2054050T3 (pt)
ES (1) ES2392883T3 (pt)
MY (1) MY148277A (pt)
NZ (1) NZ574216A (pt)
PT (1) PT2054050E (pt)
RS (1) RS52710B (pt)
SI (1) SI2054050T1 (pt)
UA (1) UA99818C2 (pt)
ZA (1) ZA200900426B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2880179B1 (en) * 2012-08-06 2017-12-13 Merck Patent GmbH Genetic markers for predicting responsiveness to fgf-18 compound
HRP20181570T1 (hr) * 2014-02-20 2018-11-30 Merck Patent Gmbh Režim doziranja spoja fgf-18
KR102437057B1 (ko) * 2014-02-20 2022-08-26 메르크 파텐트 게엠베하 이식편 이식 및 조직 공학 절차에 있어서의 ｆｇｆ－１８
ES2698117T3 (es) * 2014-02-20 2019-01-31 Merck Patent Gmbh Implante que comprende FGF-18
EP3250223A1 (en) * 2015-01-08 2017-12-06 University of Iowa Research Foundation Methods for the regeneration of articular cartilage in vivo
US11020454B2 (en) 2015-07-15 2021-06-01 Prosit Sole Biotechnology (Beijing) Co. Ltd Fusion polypeptides and methods of use
CA2994638A1 (en) * 2015-08-13 2017-02-16 Merck Patent Gmbh Combination composition comprising fgf-18 compound
WO2020263989A1 (en) 2019-06-24 2020-12-30 University Of Iowa Research Foundation Jnk inhibitors as anticancer agents
EP4061836A4 (en) * 2019-11-21 2024-02-14 Remedium Bio, Inc. GROWTH FACTOR RESTORATION
US11904006B2 (en) 2019-12-11 2024-02-20 University Of Iowa Research Foundation Poly(diaminosulfide) particle-based vaccine
CN117721115A (zh) * 2022-09-06 2024-03-19 深圳瑞吉生物科技有限公司 用于治疗骨关节炎的mRNA及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1551426B1 (en) * 2002-10-07 2014-06-25 ZymoGenetics, Inc. Methods of administering fgf18
WO2006014444A1 (en) * 2004-07-06 2006-02-09 Zymogenetics, Inc. Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use
DK1828239T3 (da) * 2004-12-10 2011-12-19 Zymogenetics Inc FGF18-produktion i prokaryote værter

Also Published As

Publication number Publication date
CN101505787B (zh) 2013-09-04
ES2392883T3 (es) 2012-12-14
ZA200900426B (en) 2010-04-28
PT2054050E (pt) 2012-09-17
CN101505787A (zh) 2009-08-12
MY148277A (en) 2013-03-29
RS52710B (sr) 2013-08-30
SI2054050T1 (sl) 2012-12-31
BRPI0715728A8 (pt) 2018-04-03
UA99818C2 (ru) 2012-10-10
DK2054050T3 (da) 2012-09-03
NZ574216A (en) 2011-11-25

Similar Documents

Publication Publication Date Title
BRPI0811265A2 (pt) Tratamento de sinucleinopatias
DK2982696T3 (da) Behandling af akut lymfoblastær leukæmi
DK1986633T3 (da) Behandling af duchennes muskeldystrofi
EP2124523A4 (en) BREEDING LINE P2428-5006090
BRPI0910854A2 (pt) métodos de tratamento
DK2222272T3 (da) Behandling af luftvejssygdom
DK2350116T3 (da) Behandling af biofilm
PL2338519T3 (pl) Środek do leczenia zwłóknienia szpiku
DK2373927T3 (da) Behandling af forbrændingsgas fra affaldsbehandling
BRPI0815551A2 (pt) Tratamento através de hucbc de doença beta-amiloide
DK2173831T3 (da) Brøndbehandling
EP2110789A4 (en) PAPER MONEY PROCESSOR
BRPI0821652A2 (pt) tratamento de biocombustíveis
BRPI0715728A8 (pt) tratamento de distúrbios cartilaginosos
EP3381471C0 (en) PAIN TREATMENT
BRPI0916079A2 (pt) tratamento de água marinha residual
DK2056858T3 (da) Behandling af lungesygdomstilstande
BRPI0812087A2 (pt) Processos de formação de pré-formas de silenciosos
ZA200901452B (en) Treatment of vertigo with acetyl-L-leucine
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
DK2175849T3 (da) Behandling af melanomer
DK2190451T3 (da) Behandling af atherosklerose
DK2222289T3 (da) Behandling af oral pharyngeal dysphagi
HRP20160577T1 (hr) Liječenje osteoartritisa
BRPI0811625A2 (pt) Métodos de tratamento de distúrbios cognitivos através da inibição da gpr12

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]